| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 杨松 | 天风证券 | 医药生物 | 27.21% | 19.39% | 21.91% | -45.36% | 24 | -72.65% | 2025-06-10 |
| 2 | 周豫 | 太平洋 | 医药生物 | 27.21% | 30.60% | 12.14% | 20.00% | 23 | -55.62% | 2025-07-04 |
| 3 | 王班 | 民生证券 | 医药生物 | 27.21% | 32.19% | 23.77% | -21.43% | 15 | -61.25% | 2025-07-15 |
| 4 | 华挺 | 财通证券 | 医药生物 | 27.21% | 27.21% | 4.50% | -6.67% | 4 | -50.33% | 2025-07-01 |
| 5 | 华挺 | 财通证券 | 医药生物 | 27.20% | 24.38% | 11.32% | -6.67% | 4 | -50.33% | 2025-06-18 |
| 6 | 华挺 | 财通证券 | 医药生物 | 27.19% | 23.93% | 13.28% | -6.67% | 4 | -50.33% | 2025-06-17 |
| 7 | 仰佳佳 | 申万宏源 | 医药生物 | 27.11% | 31.39% | 5.02% | 16.67% | 1 | -37.64% | 2025-07-04 |
| 8 | 王斌 | 首创证券 | 医药生物 | 27.09% | 31.78% | 18.73% | -3.03% | 20 | -54.62% | 2025-07-15 |
| 9 | 韩世通 | 中信证券 | 医药生物 | 27.09% | 28.88% | 10.65% | -8.70% | 5 | -63.25% | 2025-07-02 |
| 10 | 杨松 | 天风证券 | 医药生物 | 26.97% | 28.85% | 20.85% | -45.36% | 20 | -72.65% | 2025-07-14 |
| 11 | 张林晚 | 上海证券 | 医药生物 | 26.97% | 23.17% | 18.56% | -100.00% | 1 | -18.93% | 2025-06-25 |
| 12 | 唐寅灏 | 中信证券 | 医药生物 | 26.96% | 21.64% | 28.96% | 60.00% | 6 | -8.47% | 2025-04-02 |
| 13 | 周豫 | 太平洋 | 医药生物 | 26.93% | 18.61% | 16.66% | 20.00% | 23 | -55.62% | 2025-06-11 |
| 14 | 刘浩 | 华创证券 | 医药生物 | 26.91% | 38.39% | 25.37% | 20.00% | 1 | -47.33% | 2025-03-28 |
| 15 | 阳景 | 浦银国际证券 | 医药生物 | 26.90% | 40.74% | 1.68% | 100.00% | 4 | 0.00% | 2025-05-23 |
| 16 | 阳景 | 浦银国际证券 | 医药生物 | 26.88% | 61.14% | 25.17% | 100.00% | 2 | 0.00% | 2025-03-20 |
| 17 | 吴春红 | 江海证券 | 医药生物 | 26.86% | 21.11% | 13.79% | 27.27% | 6 | -25.67% | 2025-06-23 |
| 18 | 仰佳佳 | 申万宏源 | 医药生物 | 26.86% | 29.23% | 25.09% | 16.67% | 1 | -37.64% | 2025-05-07 |
| 19 | 王班 | 民生证券 | 医药生物 | 26.84% | 32.24% | 25.57% | -21.43% | 15 | -61.25% | 2025-07-16 |
| 20 | 袁聪敏 | 中信证券 | 医药生物 | 26.82% | 20.69% | 31.66% | 33.33% | 5 | -2.06% | 2025-04-11 |